drugset / Trial / NCT04560465

Efficacy of Tranexamic Acid in Reducing Myomectomy Associated Blood Loss in Federal Teaching Hospital Abakaliki.

NCT04560465 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

to determine safety and efficacy of Tranexamic Acid in reducing blood loss during Myomectomy in our institution.

Timeline

Start
2018-06-01
Primary completion
2019-05-31
Completion
2019-06-01

Outcome

Met primary endpoint

paper Perioperative tranexamic acid infusion therefore reduced mean intraoperative blood loss by 300 ml, and this was statistically significant (SMD = -0.212, 95% CI: -403.932 to -196.067, P < 0.0001). PMID 38283394 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1000 mg Intravenous

Indications

No indication recorded.